1. Home
  2. Stock quotes
  3. Travere Therapeutics
  4. Financial Ratios
  5. EV/EBITDA Ratio
Travere Therapeutics logo
Travere Therapeutics TVTX
$ 18.4 -0.89%
mail-toReport an Error

Quarterly report 2024-Q3
added 10-31-2024

report update icon

Travere Therapeutics EV/EBITDA Ratio 2011-2024 | TVTX

Annual EV/EBITDA Ratio Travere Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-14.2 -35.2 - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-14.2 -35.2 -24.7